Immunosuppression and tumor development in organ transplant recipients: the emerging dualistic role of rapamycin
Article
Gaumann, Andreas, Schlitt, Hans J. and Geissler, Edward K. (2008) Immunosuppression and tumor development in organ transplant recipients: the emerging dualistic role of rapamycin. Transplant International 21 (3), pp. 207-217.Alternative links to fulltext
Involved Institutions
Details
| Item type | Article | ||||
| Journal or Publication Title | Transplant International | ||||
| Publisher | BLACKWELL PUBLISHING | ||||
| Place of Publication | OXFORD | ||||
| Volume | 21 | ||||
| Number of Issue or Book Chapter | 3 | ||||
| Page Range | pp. 207-217 | ||||
| Date | 2008 | ||||
| Date of publication | 19 Dec 2024 13:23 | ||||
| Institutions | Medicine > Lehrstuhl für Chirurgie Medicine > Lehrstuhl für Pathologie | ||||
| Identification Number |
| ||||
| Keywords | MULTIPLE-MYELOMA CELLS; EPSTEIN-BARR-VIRUS; PHASE-II TRIAL; POSTTRANSPLANT LYMPHOPROLIFERATIVE DISORDERS; RECURRENT MALIGNANT GLIOMA; ENDOTHELIAL GROWTH-FACTOR; HIPPEL-LINDAU PROTEIN; MAMMALIAN TARGET; KAPOSIS-SARCOMA; HEPATOCELLULAR-CARCINOMA; cancer; mammalian target of rapamycin; rapamycin; transplantation | ||||
| Dewey Decimal Classification | 600 Technology > 610 Medical sciences Medicine | ||||
| Status | Published | ||||
| Refereed | Yes, this version has been refereed | ||||
| Created at the University of Regensburg | Yes | ||||
| Item ID | 68373 |
Export bibliographical data
Owner only: item control page
Altmetric
Altmetric